IFG Advisory’s Quest Diagnostics DGX Stock Holding History

IFG Advisory’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	+1,523	New	+$299K	0.01%	724
2022 Q2	–	Sell	-2,301	Closed	-$314K	–	479
2022 Q1	$314K	Sell	2,301 -852	-27%	-$119K	0.03%	388
2021 Q4	$545K	Hold	3,153	–	–	0.05%	283
2021 Q3	$458K	Sell	3,153 -24	-0.8%	-$3.51K	0.05%	312
2021 Q2	$419K	Sell	3,177 -807	-20%	-$106K	0.05%	328
2021 Q1	$511K	Buy	3,984 +1,815	+84%	+$224K	0.06%	296
2020 Q4	$258K	Hold	2,169	–	–	0.04%	381
2020 Q3	$248K	Hold	2,169	–	–	0.04%	358
2020 Q2	$247K	Buy	+2,169	New	+$230K	0.04%	341
2020 Q1	–	Sell	-2,316	Closed	-$247K	–	374
2019 Q4	$247K	Hold	2,316	–	–	0.05%	352
2019 Q3	$247K	Sell	2,316 -1,917	-45%	-$197K	0.05%	339
2019 Q2	$430K	Buy	4,233 +105	+3%	+$10.1K	0.08%	221
2019 Q1	$371K	Buy	4,128 +274	+7%	+$23.7K	0.07%	233
2018 Q4	$320K	Sell	3,854 -404	-9%	-$37.9K	0.08%	236
2018 Q3	$459K	Sell	4,258 -535	-11%	-$58.7K	0.09%	225
2018 Q2	$526K	Buy	4,793 +218	+5%	+$22.7K	0.11%	183
2018 Q1	$458K	Sell	4,575 -864	-16%	-$88.5K	0.1%	194
2017 Q4	$535K	Buy	+5,439	New	+$516K	0.12%	166

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

IFG Advisory's DGX Position: Q2 2026 in Review

IFG Advisory opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,523 shares worth $323K. The stake represents 0.01% of the portfolio and ranks #724 among its holdings. This is a return to the name: IFG Advisory previously reported a position in DGX as recently as Q1 2022.

IFG Advisory first reported a position in DGX in Q4 2017 and has held it in 18 quarters since. The position peaked at $545K in Q4 2021. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

IFG Advisory held 1,523 shares of Quest Diagnostics worth $323K as of Q2 2026.
Quest Diagnostics was a new IFG Advisory position in Q2 2026.
Quest Diagnostics made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #724 holding.
IFG Advisory first reported a position in Quest Diagnostics in Q4 2017 and has held it in 18 quarters since.
IFG Advisory's Quest Diagnostics position peaked at $545K in Q4 2021.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.